<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="uk">
		<id>http://istoriya.soippo.edu.ua/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Trialhelium46</id>
		<title>HistoryPedia - Внесок користувача [uk]</title>
		<link rel="self" type="application/atom+xml" href="http://istoriya.soippo.edu.ua/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Trialhelium46"/>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=%D0%A1%D0%BF%D0%B5%D1%86%D1%96%D0%B0%D0%BB%D1%8C%D0%BD%D0%B0:%D0%92%D0%BD%D0%B5%D1%81%D0%BE%D0%BA/Trialhelium46"/>
		<updated>2026-04-20T21:15:04Z</updated>
		<subtitle>Внесок користувача</subtitle>
		<generator>MediaWiki 1.24.1</generator>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Stem_Cells_Quadriplegic&amp;diff=195907</id>
		<title>Stem Cells Quadriplegic</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Stem_Cells_Quadriplegic&amp;diff=195907"/>
				<updated>2017-06-29T15:00:20Z</updated>
		
		<summary type="html">&lt;p&gt;Trialhelium46: Створена сторінка: Taketomi A, Yamashita Y, Shirabe K, Hamatsu T, et al. Clinical significance of histone deacetylase 1 expression in individuals with hepatocellular carcinoma. On...&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Taketomi A, Yamashita Y, Shirabe K, Hamatsu T, et al. Clinical significance of histone deacetylase 1 expression in individuals with hepatocellular carcinoma. Oncology 72: 6974. 41. Hsu HC, Tseng HJ,  Lai PL, Lee PH, Peng SY Expression of p53 gene in 184 unifocal hepatocellular carcinomas: association with tumor development and invasiveness. [http://www.medchemexpress.com/HG6-64-1.html HG6-64-1] cancer Res 53: 46914694. 42. Vleugel MM, Shvarts D, van der Wall E, van Diest PJ p300 and p53 levels establish activation of HIF-1 downstream targets in invasive breast cancer. Hum Pathol 37: 10851092. 43. Yamada A, Fujii S, Daiko H, Nishimura M, Chiba T, et al. Aberrant  expression of EZH2 is related with a poor outcome and P53 alteration in squamous cell carcinoma in the esophagus. Int J Oncol 38: 345353. 44. Tang X, Milyavsky M, Shats I, Erez N, Goldfinger N, et al. Activated p53 suppresses the histone methyltransferase EZH2 gene. Oncogene 23: 57595769. 45. Di Agostino S, Strano S, Emiliozzi V, Zerbini V, Mottolese M, et al. Get of function of mutant p53: the mutant p53/NF-Y protein complex reveals an aberrant transcriptional mechanism of cell cycle regulation. Cancer Cell 10: 191202. 9 ~~ ~~ Several myeloma is among the most typical hematologic malignancies with poor prognosis, characterized by neoplastic proliferation of monoclonal plasma cells. The incidence of MM in developed nations is about 57 instances per 100 000 men and women. In spite of in depth investigation efforts more than the last two decades, the threat things of MM stay to become established. Several case-control and cohort studies to date have recommended that several environmental elements could possibly be associated with all the risk of MM, including ionizing radiation, benzene and agricultural occupation. The connection amongst autoimmune illness and hematopoietic malignancies was initially postulated in 1964. Nonetheless, the challenge of no matter if autoimmune diseases enhance the incidence of MM remains controversial. On the basis of animal models of MM, it's suggested that repeated antigenic stimulation in the immune method plays a crucial role in MM development. Several research have confirmed an association of lymphoma with autoimmune circumstances, like rheumatoid arthritis, systemic lupus erythematosus, and autoimmune hemolytic anemia, even though the underlying pathogenesis is unclear. Similarly, the partnership between MM and autoimmune disease has been a long-term subject of investigation, but inconsistent results have already been obtained to date. The principle aim of this meta-analysis was to estimate the comparative threat of establishing MM in RA sufferers versus the common population. Two further targets were to discover the variation within the association of RA and MM amongst subgroups of interest and to investigate if there is certainly an association involving MM and also other autoimmune diseases. Approaches Search Technique A literature search was conducted with PubMed, EMBASE and Net of Science working with the following search terms: rheumatoid arthritis, autoimmune disease, etiology, epidemiology, Many Myeloma in Rheumatoid Arthritis threat factors, numerous myeloma, cancer, malignancy. The final search approach in PubMed was attached as appendix. The final literature search was performed on December 25, 2013. We also searched annual meeting abstracts with the American Society of Hematology from 2004 to 2013 to determine eligible unpublished information. All references cited within the retrieved articles had been on top of that reviewed to indentify further eligible research.&lt;/div&gt;</summary>
		<author><name>Trialhelium46</name></author>	</entry>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Stem_Cells_Japanese_Researcher&amp;diff=194862</id>
		<title>Stem Cells Japanese Researcher</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Stem_Cells_Japanese_Researcher&amp;diff=194862"/>
				<updated>2017-06-27T10:06:42Z</updated>
		
		<summary type="html">&lt;p&gt;Trialhelium46: Створена сторінка: s appeared to occur independently, concurrent activation of acetylation and methylation at the identical residue, H3K27, was observed inside a subset of HCC wit...&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;s appeared to occur independently, concurrent activation of acetylation and methylation at the identical residue, H3K27, was observed inside a subset of HCC with poorly-differentiated morphology and p53 abnormality, plus the individuals with this subset of HCC showed poor prognosis compared with other folks. These benefits couldn't be obtained without the precise quantification of immunohistochemical results in the present study. We confirmed that the method is feasible and reproducible. The obtained information represented pretty well subtle differences among the circumstances, as illustrated inside the scatter diagram. Furthermore, each modifications showed different nuclear localization patterns in individual cancer cells; H3K27ac was localized inside the central euchromatin regions, although H3K27me3 was observed within the peripheral heterochromatin regions. H3K27ac acts as an active enhancer, even though H3K27me3 acts as a silencer. Hence, the segregated localization may possibly reflect compartmentalization of oncogenes related to proliferation or invasion and tumor suppressor genes related to apoptosis or differentiation within the nucleus. H3K27ac [http://www.medchemexpress.com/HG6-64-1.html HG6-64-1] Modification is induced by p300/CBP and removed by HDACs, though H3K27me3 is induced by EZH2 and removed by JMJD3. Previous studies revealed the clinicopathological significance of expression of those modification enzymes. Higher expression of p300 in HCC correlated with poor differentiation and poor prognosis and higher expression of EZH2 in HCC correlated with poor differentiation. As for H3K27ac, high expressions of some HDACs in HCC also correlated with dedifferentiation and worse survival. These information are consistent with our results, but  additional studies are necessary to evaluate which targets are improved for the patient stratification, either the modifying enzymes or the histone modifications. The HCC subgroup with concurrently high H-scores of H3K27ac and H3K27me3 showed considerable correlation with constructive staining of p53. Constructive p53 staining has been noted to correlate with p53 mutation in HCC. The correlation of p53 abnormality with p300 and EZH2 has been recognized in numerous cancers. Nuclear accumulation of p53 was connected with p300 expression in breast cancer and with EZH2 expression in squamous cell carcinoma of esophagus. In an in vitro study, overexpression of mutant p53 upregulated EZH2 expression. Di Agostino et al. demonstrated that mutant p53 is in a position to recruit p300 and cause histone acetylation in some promoter regions. For that reason, some of the p53 abnormalities might lead to concurrent improve of H3K27ac and H3K27me3 levels by means of mechanisms that have not been investigated however. In summary, concurrent activation of acetylation and methylation on H3K27 happens within the subgroup of HCC, displaying p53positive poorly differentiated sort. Additional research are necessary to evaluate the attainable association between p53 plus the concurrent raise of histone modification. Our findings demonstrate that image analyzer-assisted H-scores of H3K27ac and H3K27me3 identified an aggressive subgroup of HCC, and could serve as a prognostic marker for HCC. Additional ROC analysis supports 7 H3K27 Modification in Hepatocellular Carcinoma the possibility that the H3K27 modification could predict more accurately in HCC than other prognostic indicators or markers. Supporting Information and facts Acknowledgments We are grateful to  Akiko Kunita, Ryu Miyagawa, Yumiko Nagano, Harumi Yamamura, and Kei Sakuma for their critical advices and outstanding technical support. Aut&lt;/div&gt;</summary>
		<author><name>Trialhelium46</name></author>	</entry>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Stem_Cells_Are&amp;diff=194823</id>
		<title>Stem Cells Are</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Stem_Cells_Are&amp;diff=194823"/>
				<updated>2017-06-27T08:30:49Z</updated>
		
		<summary type="html">&lt;p&gt;Trialhelium46: Створена сторінка: ct Funct 33: 6173. 22. Van Den Broeck A, Brambilla E, Moro-Sibilot D, Lantuejoul S, Brambilla C, et al. Loss of histone H4K20 trimethylation happens in preneopl...&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;ct Funct 33: 6173. 22. Van Den Broeck A, Brambilla E, Moro-Sibilot D, Lantuejoul S, Brambilla C, et al. Loss of histone H4K20 trimethylation happens in preneoplasia and influences prognosis of non-small cell lung cancer. Song L, Robson T, Doig T, Brenn T, Mathers M, et al. DNA repair and replication proteins as prognostic markers in melanoma. Histopathology 62: 343350. 24. Tamagawa H, Oshima T, Numata M, Yamamoto N, Shiozawa M, et al. Worldwide histone modification of H3K27 correlates together with the outcomes in individuals with metachronous liver metastasis of colorectal cancer. Eur J Surg Oncol 39: 655661. 25. Torbenson M, Kannangai R, Abraham S, Sahin F, Choti M, et al. Concurrent evaluation of p53, [http://www.medchemexpress.com/GW2580.html 870483-87-7] beta-catenin, and alpha-fetoprotein expression in human hepatocellular carcinoma. Am J Clin Pathol 122: 377382. 26. Salichs E, Ledda A, Mularoni L, Alba MM, de la Luna S Genome-wide analysis of histidine repeats reveals their function in the localization of human proteins to the nuclear speckles compartment. PLoS Genet five: e1000397. 27. Bland JM, Altman DG Numerous significance tests: the Bonferroni approach. BMJ 310: 170. 28. Blanche P, Dartigues JF, Jacqmin-Gadda H Estimating and comparing time-dependent locations beneath receiver operating characteristic curves for censored occasion times with competing dangers. Stat Med 32: 53815397. 29. Heagerty PJ, Lumley T, [http://www.ncbi.nlm.nih.gov/pubmed/ 23148522  23148522] Pepe MS Time-dependent ROC curves for censored survival data in addition to a diagnostic marker. Biometrics 56: 337344. 30. Ho WH, Lee KT, Chen HY, Ho TW, Chiu HC Disease-free survival immediately after hepatic resection in hepatocellular carcinoma patients: a prediction approach employing artificial neural network. PLoS One 7: e29179. 31. Tandon P, Garcia-Tsao G Prognostic indicators in hepatocellular carcinoma: a systematic overview of 72 research. Liver Int 29: 502510. 32. Littau VC, Allfrey VG, Frenster JH, Mirsky AE Active and Inactive Regions of Nuclear Chromatin as Revealed by Electron Microscope Autoradiography. Proc Natl Acad Sci U S A 52: 93100. 33. Chen X, Cheung ST, So S, Fan ST, Barry C, et al. Gene expression patterns in human liver cancers. Mol Biol Cell 13: 19291939. 34. Integrative transcriptome analysis reveals typical molecular subclasses of human hepatocellular carcinoma. Cancer Res 69: 73857392. 35. Yokomizo C, Yamaguchi K, Itoh Y, Nishimura T, Umemura A, et al. Higher expression of p300 in HCC predicts shortened all round survival in association with enhanced epithelial mesenchymal transition of HCC cells. Cancer Lett 310: 140147. 36. Li M, Luo RZ, Chen JW, Cao Y, Lu JB, et al. Higher expression of transcriptional coactivator p300 correlates with aggressive options and poor prognosis of hepatocellular carcinoma. J Transl Med 9: 5. 37. Sudo T, Utsunomiya T, Mimori K, Nagahara H, Ogawa K, et al. Clinicopathological significance of EZH2 mRNA expression in patients 	 with hepatocellular carcinoma. Br J Cancer 92: 17541758. 38. Sasaki M, Ikeda H, Itatsu K, Yamaguchi J, Sawada S, et al. The overexpression of polycomb group proteins Bmi1 and EZH2 is associated with all the progression and aggressive biological behavior of hepatocellular carcinoma. Lab Invest 88: 873882. 39. Quint K, Agaimy A, Di Fazio P, Montalbano R, Steindorf C, et al. Clinical significance of histone deacetylases 1, two, three, and 7: HDAC2 is definitely an independent predictor of survival in HCC. Virchows Arch 459: 129139. eight H3K27 Modification in Hepatocellular Carcinoma 40. Rikimaru T,&lt;/div&gt;</summary>
		<author><name>Trialhelium46</name></author>	</entry>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Stem_Cells_Treatment_For_Autism&amp;diff=191170</id>
		<title>Stem Cells Treatment For Autism</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Stem_Cells_Treatment_For_Autism&amp;diff=191170"/>
				<updated>2017-06-19T10:39:54Z</updated>
		
		<summary type="html">&lt;p&gt;Trialhelium46: Створена сторінка: : human participants without the need of limitation of sex or geographic place, case-control or cohort studies, prior healthcare history of RA as exposure, MM a...&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;: human participants without the need of limitation of sex or geographic place, case-control or cohort studies, prior healthcare history of RA as exposure, MM as outcome, research that reported relative risk, standardized incidence ratio or odds ratio of MM individuals with prior history of RA, publication in English. Moreover, the choice of cohort studies for inclusion was created irrespective of precise RA management strategies. When duplicate reports for precisely the same population and information supply were eligible, we chose the original reports together with the biggest sample size. Case series, case reports, in vitro and animal studies have been excluded. Eligibility assessment was performed independently by two reviewers, and disagreements resolved by consensus. The Newcastle-Ottawa Scale, created for evaluating the excellent of nonrandomized studies, was made use of by two independent reviewers to assess the methodological top quality of every study, and the scores subsequently made use of in subgroup analysis. A score of #5 was considered as relative low high-quality. Statistical Analyses In case-control studies, OR and 95% CIs for MM risk factors have been straight extracted from original investigation papers or calculated when not provided. The major outcome for cohort research was SIR and corresponding 95% CI. In cases exactly where SIRs were not particularly reported, calculations were made from the variety of observed MM divided by the amount of expected cases within the general population supplied by authors, and 95% CI determined employing the normal error with the natural logarithm of SIR, estimated from the inverse in the square root on the observed variety of cases. The measure of interest was RR, estimated from ORs in case-control research and SIRs in cohort studies. Because the incidence of MM is low, SIR and OR create comparable estimate of RR, as a result we present all benefits as RR for simplicity. Between-study heterogeneity was examined working with a chi-square test of heterogeneity and I2 measure of inconsistency. P-values much less than 0.1 or the I2 statistic greater than 50% were regarded as statistically substantial. Under these situations, data had been pooled based around the method of Dersimonian and Laird under a random effects model otherwise under fixed effects model. Twotailed p#0.05 was considered statistically considerable for all analyses. To evaluate publication bias, we constructed a funnel plot and applied Begg's test. Trim and Fill analysis was applied to estimate the number of missing studies and their potential effects on outcomes. Sensitivity analyses had been furthermore conducted to ascertain the robustness of our findings. The [http://www.medchemexpress.com/GW-4064.html MedChemExpress 278779-30-9] influence of RA was examined by excluding studies restricted to elderly individuals or Data Extraction Two authors performed data extraction independently, and any discrepancies were addressed by discussion and re-evaluation. We obtained facts on the author, year of publication, nation of origin, supply of case, control and cohort, controlled things, diagnosis criteria and treatment regimen for RA. Cohort size, variety of cases, cohort duration, SIR and 95% self-confidence intervals or sufficient data to allow calculation of those numbers had been on top of that essential for  cohort research. For casecontrol research, the precise numbers of cases and controls by RA, OR and 95% CIs were needed. For the goal of ascertaining the connection between MM and other  autoimmune diseases, connected information had been recorded, exactly where available, as outlined by the above extraction principles. two Author RA M M+F M+F M+F M+F&lt;/div&gt;</summary>
		<author><name>Trialhelium46</name></author>	</entry>

	</feed>